Different effects of anti-TNF-alpha biologic drugs on the small bowel macroscopic inflammation in patients with ankylosing spondylitis

Background & Aims. Considering the ability of anti-TNF alpha drugs to lower the burden intestinal inflammation in patients with inflammatory bowel disease (IBD), and the similarity between IBD and ankylosing spondylitis (AS) regarding inflammatory intestinal involvement, we aimed to investigate...

Full description

Saved in:
Bibliographic Details
Main Authors: Chitul A. (Author), Voiosu A.M (Author), Marinescu Mădălina (Author), Caraiola Simona (Author), Nicolau Adriana (Author), Badea Georgeta Camelia (Author), Pârvu Magda Ileana (Author), Ionescu R. A. (Author), Mateescu B. R. (Author), Voiosu M. R. (Author), Băicuş C. R. (Author), Rimbaş M. (Author)
Format: Book
Published: Sciendo, 2017-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background & Aims. Considering the ability of anti-TNF alpha drugs to lower the burden intestinal inflammation in patients with inflammatory bowel disease (IBD), and the similarity between IBD and ankylosing spondylitis (AS) regarding inflammatory intestinal involvement, we aimed to investigate the impact of anti-TNF alpha biologic therapy on subclinical intestinal inflammation in AS patients.
Item Description:2501-062X
10.1515/rjim-2017-0001